New Zealand markets closed

Bora Pharmaceuticals Co., LTD. (6472.TW)

Taiwan - Taiwan Delayed price. Currency in TWD
Add to watchlist
765.00-10.00 (-1.29%)
At close: 01:30PM CST

Bora Pharmaceuticals Co., LTD.

No. 2, Ruiguang Road
6th Floor Aly. 36, Ln. 26 Neihu District
Taipei City 114
Taiwan
886 2 2790 1555
https://www.bora-corp.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees

Description

Bora Pharmaceuticals Co., LTD. researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide. The company operates through Sales, Contract Development & Manufacturing Organization, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services, including clinical and commercial manufacturing, pharmaceutical development, packaging and serialization, analytical and microbiology testing, and regulatory affairs services. In addition, it provides food and vitamin supplements, and skincare products; and biotechnical services. The company sells its products directly to clinics, pharmacies, pharmacy chains, and drug stores, as well as through distributors to medical centers, corporate and public hospitals, and regional and district hospitals. Bora Pharmaceuticals Co., LTD. was incorporated in 2007 and is based in Taipei City, Taiwan.

Corporate governance

Bora Pharmaceuticals Co., LTD.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.